The placement of IVC Filters (inferior vena cava filters) without subsequent retrieval may be one of the main reasons that IVC thrombosis is on the rise, according to MedPage Today.
It is estimated that IVC thrombosis accounts for 2.6 to 4.0 percent of deep vein thrombosis cases.
IVC thrombosis is an unwanted adverse event that occurs mainly after IVC filter insertion; therefore, IVC filters should only be used for proper indications, and if an IVC filter is inserted, it should be a retrievable type, as the filter needs to come out as soon as possible, as recommended by the FDA.
In August 2010, the FDA issued a warning stating that the agency had received 921 adverse event reports concerning IVC filters.
The FDA has subsequently concluded that the risk of injury may outweigh any potential benefits of implanting IVC filters, and the FDA advised physicians to remove the filters as soon as the danger of blood clots has passed.
The warning was updated in May 2014, when the FDA encouraged all physicians involved in the treatment and follow-up of patients receiving IVC filters to consider the risks and benefits of filter removal for each patient.
At that time, the FDA also required manufacturers to collect additional clinical data addressing safety questions for currently marketed IVC filters in the U.S.
Common complications with IVC filters left in the body for long periods of time include:
There are currently no guidelines on the time frame during which IVC filters must be retrieved from the body, and according to the U.S. Food and Drug Administration (FDA), the majority of IVC filters are not retrieved, despite the perceived risk of increased fracture, embolism, and IVC wall penetration.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
512 cases (2,048 trays) of Gordon Food Service (GFS) Sienna Bakery® Chocolate Decadent Brownies (GFS#226240) and Sienna Bakery® Chocolate Peanut Butter Brownies have been recalled by Dianne’s Fine Desserts due to a mislabeling and undeclared peanut, according to the FDA. Consumers who are allergic or
According to the FDA, Baxter Healthcare Corporation’s September 21, 2023 recall of its Novum IQ Syringe Pump is now identified as Class I, the most serious type, because use of the device has been found to put users at risk of serious injuries or death.
Publix Supermarkets, Inc., of Lakeland, Florida, has voluntarily recalled certain batches of private-label Egg Custard Pie sold between October 20, 2023 and November 16, 2023 because they may contain coconut, an allergen not listed on the product’s ingredient statement. Officials say the affected packages, which